Mostrar el registro sencillo del ítem

dc.contributor.authorJimenez-Garcia, Lidia 
dc.contributor.authorHerranz, Sandra 
dc.contributor.authorHigueras, María Angeles
dc.contributor.authorLuque, Alfonso 
dc.contributor.authorHortelano, Sonsoles 
dc.date.accessioned2020-04-17T16:11:36Z
dc.date.available2020-04-17T16:11:36Z
dc.date.issued2016-10-11
dc.identifier.citationOncotarget. 2016 Oct 11;7(41):66835-66850. des_ES
dc.identifier.issn1949-2553es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9616
dc.description.abstractTumor microenvironment has been described to play a key role in tumor growth, progression, and metastasis. Macrophages are a major cellular constituent of the tumor stroma, and particularly tumor associated macrophages (TAMs or M2-like macrophages) exert important immunosuppressive activity and a pro-tumoral role within the tumor microenvironment. Alternative-reading frame (ARF) gene is widely inactivated in human cancer. We have previously demonstrated that ARF deficiency severely impairs inflammatory response establishing a new role for ARF in the regulation of innate immunity. On the basis of these observations, we hypothesized that ARF may also regulates tumor growth through recruitment and modulation of the macrophage phenotype in the tumor microenvironment. Xenograft assays of B16F10 melanoma cells into ARF-deficient mice resulted in increased tumor growth compared to those implanted in WT control mice. Tumors from ARF-deficient mice exhibited significantly increased number of TAMs as well as microvascular density. Transwell assays showed crosstalk between tumor cells and macrophages. On the one hand, ARF-deficient macrophages modulate migratory ability of the tumor cells. And on the other, tumor cells promote the skewing of ARF-/- macrophages toward a M2-type polarization. In conclusion, these results demonstrate that ARF deficiency facilitates the infiltration of macrophages into the tumor mass and favors their polarization towards a M2 phenotype, thus promoting tumor angiogenesis and tumor growth. This work provides novel information about the critical role of ARF in the modulation of tumor microenvironment.es_ES
dc.description.sponsorshipThis study was supported by grant PI11.0036 and PI14.0055 from the FIS, MPY 1410/09 from ISCIII and Spanish Ministry of Health (Instituto de Salud Carlos III; RD12/0036/0059) to SH, and by grant TPY-M-1068/13 and IERPY 1149/16 to AL. L J-G was supported by FIS (FI12/00340). AL was supported by FIS (CP12/03087). S Herranz was supported by TPY-M-1068/13 from ISCIII. We thank Fernando González Camacho and Silvia Hernández Esteban for Confocal Microscopy assistance.es_ES
dc.language.isoenges_ES
dc.publisherImpact Journals es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectARFes_ES
dc.subjectM2-polarizationes_ES
dc.subjectangiogenesises_ES
dc.subjectmacrophagees_ES
dc.subjecttumor-microenvironmentes_ES
dc.subject.meshAnimals es_ES
dc.subject.meshCell Line, Tumor es_ES
dc.subject.meshCell Movement es_ES
dc.subject.meshHumans es_ES
dc.subject.meshMacrophage Activation es_ES
dc.subject.meshMacrophages es_ES
dc.subject.meshMelanoma, Experimental es_ES
dc.subject.meshMice, Inbred C57BL es_ES
dc.subject.meshMice, Knockout es_ES
dc.subject.meshNeovascularization, Pathologices_ES
dc.subject.meshSignal Transduction es_ES
dc.subject.meshTumor Burden es_ES
dc.subject.meshTumor Microenvironment es_ES
dc.subject.meshTumor Suppressor Protein p14ARF es_ES
dc.titleTumor suppressor ARF regulates tissue microenvironment and tumor growth through modulation of macrophage polarizationes_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID27572316es_ES
dc.format.volume7es_ES
dc.format.number41es_ES
dc.format.page66835-66850es_ES
dc.identifier.doi10.18632/oncotarget.11652es_ES
dc.contributor.funderInstituto de Salud Carlos III 
dc.description.peerreviewedes_ES
dc.identifier.e-issn1949-2553es_ES
dc.relation.publisherversionhttps://doi.org/10.18632/oncotarget.11652es_ES
dc.identifier.journalOncotargetes_ES
dc.repisalud.centroISCIII::Instituto de Investigación de Enfermedades Rarases_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/PI11.0036es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/PI14.0055es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/MPY 1410/09es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/RD12/0036/0059es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/IERPY 1149/16es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/FI12/00340es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/CP12/03087es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/TPY-M-1068/13es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional